Published in Proc Natl Acad Sci U S A on April 07, 2003
The impact of retrotransposons on human genome evolution. Nat Rev Genet (2009) 8.08
Natural mutagenesis of human genomes by endogenous retrotransposons. Cell (2010) 5.50
High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res (2010) 5.38
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
LINE-1 retrotransposition activity in human genomes. Cell (2010) 4.60
Natural genetic variation caused by transposable elements in humans. Genetics (2004) 4.33
dbRIP: a highly integrated database of retrotransposon insertion polymorphisms in humans. Hum Mutat (2006) 4.23
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60
Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 3.60
Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol (2005) 3.26
A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet (2011) 3.14
Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet (2006) 3.07
The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol (2006) 2.77
Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol (2005) 2.77
L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev (2009) 2.68
SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet (2003) 2.55
LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet (2011) 2.42
Differential L1 regulation in pluripotent stem cells of humans and apes. Nature (2013) 2.29
Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res (2012) 2.29
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurosci (2010) 2.12
A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet (2005) 2.10
Active Alu retrotransposons in the human genome. Genome Res (2008) 2.09
Colloquium paper: footprints of nonsentient design inside the human genome. Proc Natl Acad Sci U S A (2010) 2.08
ATLAS: a system to selectively identify human-specific L1 insertions. Am J Hum Genet (2003) 2.00
Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res (2010) 1.94
LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res (2006) 1.94
The take and give between retrotransposable elements and their hosts. Annu Rev Genet (2008) 1.86
Recently mobilized transposons in the human and chimpanzee genomes. Am J Hum Genet (2006) 1.85
Epigenetic mechanisms in mammals. Cell Mol Life Sci (2009) 1.82
Human transposon tectonics. Cell (2012) 1.81
L1 recombination-associated deletions generate human genomic variation. Proc Natl Acad Sci U S A (2008) 1.79
LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol (2007) 1.79
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res (2007) 1.79
Selective inhibition of Alu retrotransposition by APOBEC3G. Gene (2006) 1.75
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science (2014) 1.74
Genomic rearrangements by LINE-1 insertion-mediated deletion in the human and chimpanzee lineages. Nucleic Acids Res (2005) 1.73
The insertional history of an active family of L1 retrotransposons in humans. Genome Res (2004) 1.71
Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition. Genome Res (2008) 1.69
MOV10L1 is necessary for protection of spermatocytes against retrotransposons by Piwi-interacting RNAs. Proc Natl Acad Sci U S A (2010) 1.66
Environmental influence on L1 retrotransposons in the adult hippocampus. Hippocampus (2009) 1.62
A role for retrotransposon LINE-1 in fetal oocyte attrition in mice. Dev Cell (2014) 1.59
A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res (2004) 1.59
Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev (2006) 1.58
Gene-breaking: a new paradigm for human retrotransposon-mediated gene evolution. Genome Res (2005) 1.58
Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ Health Perspect (2010) 1.58
Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet (2010) 1.56
Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J Virol (2007) 1.53
On the sequence-directed nature of human gene mutation: the role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease. Hum Mutat (2011) 1.53
All y'all need to know 'bout retroelements in cancer. Semin Cancer Biol (2010) 1.52
L1-associated genomic regions are deleted in somatic cells of the healthy human brain. Nat Neurosci (2016) 1.51
An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res (2003) 1.51
Active transposition in genomes. Annu Rev Genet (2012) 1.51
Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase. Genome Res (2007) 1.50
L1 integration in a transgenic mouse model. Genome Res (2005) 1.50
Active retrotransposition by a synthetic L1 element in mice. Proc Natl Acad Sci U S A (2006) 1.48
Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res (2014) 1.47
Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci U S A (2011) 1.45
Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum Mol Genet (2011) 1.45
Evolution of genetic and genomic features unique to the human lineage. Nat Rev Genet (2012) 1.44
Ubiquitous L1 mosaicism in hippocampal neurons. Cell (2015) 1.40
Analysis of LINE-1 Elements in DNA from Postmortem Brains of Individuals with Schizophrenia. Neuropsychopharmacology (2017) 1.39
Cell lineage analysis in human brain using endogenous retroelements. Neuron (2015) 1.39
Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEB J (2008) 1.39
Fitness cost of LINE-1 (L1) activity in humans. Proc Natl Acad Sci U S A (2006) 1.36
The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res (2011) 1.35
Affinity proteomics reveals human host factors implicated in discrete stages of LINE-1 retrotransposition. Cell (2013) 1.34
A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome. Semin Cancer Biol (2010) 1.34
LINE-1 ORF1 protein enhances Alu SINE retrotransposition. Gene (2008) 1.33
Dynamics of transposable elements: towards a community ecology of the genome. Trends Genet (2009) 1.33
LINE dancing in the human genome: transposable elements and disease. Genome Med (2009) 1.33
Evolutionally dynamic L1 regulation in embryonic stem cells. Genes Dev (2014) 1.32
Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity. Proc Natl Acad Sci U S A (2006) 1.32
Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition. Nucleic Acids Res (2013) 1.31
The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res (2004) 1.31
Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Hum Mol Genet (2011) 1.31
Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay. Nucleic Acids Res (2006) 1.30
Different evolutionary fates of recently integrated human and chimpanzee LINE-1 retrotransposons. Gene (2006) 1.26
A 3' Poly(A) Tract Is Required for LINE-1 Retrotransposition. Mol Cell (2015) 1.23
The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion. PLoS Genet (2011) 1.23
Loss of LINE-1 activity in the megabats. Genetics (2008) 1.21
SVA retrotransposons: Evolution and genetic instability. Semin Cancer Biol (2010) 1.20
Retrotransposon-derived elements in the mammalian genome: a potential source of disease. J Inherit Metab Dis (2004) 1.20
SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat Commun (2014) 1.19
Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. PLoS One (2011) 1.18
Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1. Cell Rep (2013) 1.18
Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J Biol Chem (2011) 1.18
p53 responsive elements in human retrotransposons. Oncogene (2009) 1.15
Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol (2009) 1.15
Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol Cell Biol (2010) 1.14
Discrete subcellular partitioning of human retrotransposon RNAs despite a common mechanism of genome insertion. Hum Mol Genet (2010) 1.13
Allelic heterogeneity in LINE-1 retrotransposition activity. Am J Hum Genet (2003) 1.13
Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer (2010) 1.12
Distributions of transposable elements reveal hazardous zones in mammalian introns. PLoS Comput Biol (2011) 1.12
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition. PLoS One (2008) 1.11
Assisted reproduction treatment and epigenetic inheritance. Hum Reprod Update (2012) 1.11
A single amino acid substitution in ORF1 dramatically decreases L1 retrotransposition and provides insight into nucleic acid chaperone activity. Nucleic Acids Res (2008) 1.10
Retroposition of processed pseudogenes: the impact of RNA stability and translational control. Trends Genet (2005) 1.10
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol (2012) 1.09
Basic local alignment search tool. J Mol Biol (1990) 659.07
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75
Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell (1993) 8.99
High frequency retrotransposition in cultured mammalian cells. Cell (1996) 8.60
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell (1996) 8.21
Human LINE retrotransposons generate processed pseudogenes. Nat Genet (2000) 6.64
Biology of mammalian L1 retrotransposons. Annu Rev Genet (2001) 6.52
Many human L1 elements are capable of retrotransposition. Nat Genet (1997) 6.27
Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol (2001) 5.23
Genomic deletions created upon LINE-1 retrotransposition. Cell (2002) 4.92
Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci U S A (1997) 4.80
DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet (2002) 4.58
Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet (1998) 4.01
Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol (1988) 3.99
Isolation of an active human transposable element. Science (1991) 3.99
L1 (LINE-1) retrotransposon evolution and amplification in recent human history. Mol Biol Evol (2000) 3.59
Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol (1990) 3.58
The impact of L1 retrotransposons on the human genome. Nat Genet (1998) 3.56
Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res (2000) 2.84
A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet (1994) 2.68
RNA template requirements for target DNA-primed reverse transcription by the R2 retrotransposable element. Mol Cell Biol (1995) 2.62
Targeting of human retrotransposon integration is directed by the specificity of the L1 endonuclease for regions of unusual DNA structure. Biochemistry (1998) 2.59
A comprehensive analysis of recently integrated human Ta L1 elements. Am J Hum Genet (2002) 2.47
A mouse model of human L1 retrotransposition. Nat Genet (2002) 2.39
Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum Mol Genet (1999) 2.15
Reading between the LINEs: human genomic variation induced by LINE-1 retrotransposition. Genome Res (2000) 2.09
ATLAS: a system to selectively identify human-specific L1 insertions. Am J Hum Genet (2003) 2.00
Genomic characterization of recent human LINE-1 insertions: evidence supporting random insertion. Genome Res (2001) 1.98
Two additional potential retrotransposons isolated from a human L1 subfamily that contains an active retrotransposable element. Proc Natl Acad Sci U S A (1993) 1.76
A transient assay reveals that cultured human cells can accommodate multiple LINE-1 retrotransposition events. Anal Biochem (2000) 1.71
Tracing the LINEs of human evolution. Proc Natl Acad Sci U S A (2002) 1.58
Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet (2002) 1.56
An estimated frequency of endogenous insertional mutations in humans. Nat Genet (1999) 1.52
The evolution of long interspersed repeated DNA (L1, LINE 1) as revealed by the analysis of an ancient rodent L1 DNA family. J Mol Evol (1993) 1.43
Rodent L1 evolution has been driven by a single dominant lineage that has repeatedly acquired new transcriptional regulatory sequences. Mol Biol Evol (1994) 1.36
Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat (2001) 1.33
The dynamics of murine LINE-1 subfamily amplification. J Mol Biol (1994) 1.13
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature (2005) 6.95
High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res (2010) 5.38
Genomic deletions created upon LINE-1 retrotransposition. Cell (2002) 4.92
L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol (2006) 4.80
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
LINE-1 retrotransposition activity in human genomes. Cell (2010) 4.60
DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet (2002) 4.58
Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell (2008) 4.19
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Mobile elements and mammalian genome evolution. Curr Opin Genet Dev (2003) 3.68
Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 3.60
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol (2005) 2.77
L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev (2009) 2.68
Dynamic interactions between transposable elements and their hosts. Nat Rev Genet (2011) 2.61
SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet (2003) 2.55
A comprehensive analysis of recently integrated human Ta L1 elements. Am J Hum Genet (2002) 2.47
LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet (2011) 2.42
A mouse model of human L1 retrotransposition. Nat Genet (2002) 2.39
Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res (2012) 2.29
Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat Struct Mol Biol (2006) 2.23
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood (2003) 2.21
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med (2003) 2.18
Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat (2007) 2.17
LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet (2007) 2.13
Active Alu retrotransposons in the human genome. Genome Res (2008) 2.09
L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet (2007) 2.04
Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum Mol Genet (2005) 2.02
ATLAS: a system to selectively identify human-specific L1 insertions. Am J Hum Genet (2003) 2.00
Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res (2010) 1.94
A system for Cre-regulated RNA interference in vivo. Proc Natl Acad Sci U S A (2008) 1.87
Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres. Nature (2007) 1.84
Functionally reduced sensorimotor connections form with normal specificity despite abnormal muscle spindle development: the role of spindle-derived neurotrophin 3. J Neurosci (2009) 1.84
LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol Cell Biol (2007) 1.79
Selective inhibition of Alu retrotransposition by APOBEC3G. Gene (2006) 1.75
L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci U S A (2006) 1.73
A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res (2004) 1.59
Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev (2006) 1.58
Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet (2010) 1.56
Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet (2002) 1.56
A potential role for the nucleolus in L1 retrotransposition. Hum Mol Genet (2004) 1.53
An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res (2003) 1.51
Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase. Genome Res (2007) 1.50
L1 integration in a transgenic mouse model. Genome Res (2005) 1.50
Tracking an embryonic L1 retrotransposition event. Proc Natl Acad Sci U S A (2003) 1.49
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature (2010) 1.47
Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci U S A (2011) 1.45
Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum Mol Genet (2011) 1.45
Exon-trapping mediated by the human retrotransposon SVA. Genome Res (2009) 1.44
Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice. Hum Gene Ther (2006) 1.41
Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex. J Biol Chem (2005) 1.39
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors. Mol Ther (2010) 1.38
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy. Blood (2010) 1.32
Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity. Proc Natl Acad Sci U S A (2006) 1.32
Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition. Nucleic Acids Res (2013) 1.31
Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Hum Mol Genet (2011) 1.31
SVA retrotransposons: Evolution and genetic instability. Semin Cancer Biol (2010) 1.20
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model. Blood (2009) 1.18
Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1. Cell Rep (2013) 1.18
Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J Biol Chem (2011) 1.18
MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet (2012) 1.17
Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII. Blood (2003) 1.15
Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol (2009) 1.15
SnapShot: Vertebrate transposons. Cell (2008) 1.14
Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol Cell Biol (2010) 1.14
Discrete subcellular partitioning of human retrotransposon RNAs despite a common mechanism of genome insertion. Hum Mol Genet (2010) 1.13
Allelic heterogeneity in LINE-1 retrotransposition activity. Am J Hum Genet (2003) 1.13
A novel testis ubiquitin-binding protein gene arose by exon shuffling in hominoids. Genome Res (2007) 1.07
Propionyl-CoA and adenosylcobalamin metabolism in Caenorhabditis elegans: evidence for a role of methylmalonyl-CoA epimerase in intermediary metabolism. Mol Genet Metab (2006) 1.06
A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques (2009) 1.06
Mobile elements in the human genome: implications for disease. Genome Med (2012) 1.02
Characterization of pre-insertion loci of de novo L1 insertions. Gene (2006) 1.01
Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet (2007) 1.01
More active human L1 retrotransposons produce longer insertions. Nucleic Acids Res (2004) 0.99
Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice. Hum Gene Ther (2003) 0.98
The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes. Microbiol Spectr (2015) 0.96
Pathogenic orphan transduction created by a nonreference LINE-1 retrotransposon. Hum Mutat (2011) 0.96
Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase. Proc Natl Acad Sci U S A (2011) 0.95
Enrichment of processed pseudogene transcripts in L1-ribonucleoprotein particles. Hum Mol Genet (2013) 0.93
The L1 retrotransposition assay: a retrospective and toolkit. Methods (2009) 0.92
Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum Mutat (2005) 0.92
The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol (2008) 0.90
The minimal active human SVA retrotransposon requires only the 5'-hexamer and Alu-like domains. Mol Cell Biol (2012) 0.89
Transduction-specific ATLAS reveals a cohort of highly active L1 retrotransposons in human populations. Hum Mutat (2013) 0.86
Genomic impact of eukaryotic transposable elements. Mob DNA (2012) 0.84
Characterization of a mutagenic B1 retrotransposon insertion in the jittery mouse. Hum Mutat (2004) 0.84
Genetics: LINEs in mind. Nature (2005) 0.84
L1 retrotransposon-mediated stable gene silencing. Nucleic Acids Res (2005) 0.83
RNase L restricts the mobility of engineered retrotransposons in cultured human cells. Nucleic Acids Res (2013) 0.83
Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer (2006) 0.81
In vitro screening for compounds that enhance human L1 mobilization. PLoS One (2013) 0.81
An epi [c] genetic battle: LINE-1 retrotransposons and intragenomic conflict in humans. Mob Genet Elements (2011) 0.81